Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoto Shirasu

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Biomedicine & Biotechnology|May 2, 2012
Molecular characterization of a fully human chimeric T-cell antigen receptor for tumor-associated antigen EpCAMNaoto Shirasu, Hiromi Yamada, Hirotomo Shibaguchi, et al.
Oncotargets and Therapy|September 2, 2017
Enhancement of antitumor activity by using a fully human gene encoding a single-chain fragmented antibody specific for carcinoembryonic antigenHirotomo Shibaguchi, Naixiang Luo, Naoto Shirasu, et al.
Biomed Research International|February 26, 2015
Corrigendum to "Molecular Characterization of a Fully Human Chimeric T-Cell Antigen Receptor for Tumor-Associated Antigen EpCAM"Naoto Shirasu, Hiromi Yamada, Hirotomo Shibaguchi, et al.
Cancer Cell International|December 3, 2019
Highly versatile cancer photoimmunotherapy using photosensitizer-conjugated avidin and biotin-conjugated targeting antibodiesNaoto Shirasu, Hirotomo Shibaguchi, Hiromi Yamada, et al.
Stem Cell Research|June 30, 2020
Establishment of human induced pluripotent stem cells derived from skin cells of a patient with Dravet syndromeYuichi Kimura, Yasuyoshi Tanaka, Naoto Shirasu, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|September 12, 2009
Noncompetitive immunodetection of benzaldehyde by open sandwich ELISANaoto Shirasu, Takeshi Onodera, Kazutaka Nagatomo, et al.
Anticancer Research|June 20, 2013
Possible therapeutic targets among the molecules involved in the Warburg effect in tumor cellsSung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
International Journal of Hematology|July 17, 2016
Role of Geminin in cell fate determination of hematopoietic stem cells (HSCs)Shin'ichiro Yasunaga, Yoshinori Ohno, Naoto Shirasu, et al.
Stem Cell Research|July 9, 2018
Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A geneYasuyoshi Tanaka, Norimichi Higurashi, Naoto Shirasu, et al.
Anticancer Research|May 30, 2012
Biological response modifiers used in cancer biotherapyMasahide Kuroki, Shingo Miyamoto, Takashi Morisaki, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Biomedicine & Biotechnology|May 2, 2012
Molecular characterization of a fully human chimeric T-cell antigen receptor for tumor-associated antigen EpCAMNaoto Shirasu, Hiromi Yamada, Hirotomo Shibaguchi, et al.
Oncotargets and Therapy|September 2, 2017
Enhancement of antitumor activity by using a fully human gene encoding a single-chain fragmented antibody specific for carcinoembryonic antigenHirotomo Shibaguchi, Naixiang Luo, Naoto Shirasu, et al.
Biomed Research International|February 26, 2015
Corrigendum to "Molecular Characterization of a Fully Human Chimeric T-Cell Antigen Receptor for Tumor-Associated Antigen EpCAM"Naoto Shirasu, Hiromi Yamada, Hirotomo Shibaguchi, et al.
Cancer Cell International|December 3, 2019
Highly versatile cancer photoimmunotherapy using photosensitizer-conjugated avidin and biotin-conjugated targeting antibodiesNaoto Shirasu, Hirotomo Shibaguchi, Hiromi Yamada, et al.
Stem Cell Research|June 30, 2020
Establishment of human induced pluripotent stem cells derived from skin cells of a patient with Dravet syndromeYuichi Kimura, Yasuyoshi Tanaka, Naoto Shirasu, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|September 12, 2009
Noncompetitive immunodetection of benzaldehyde by open sandwich ELISANaoto Shirasu, Takeshi Onodera, Kazutaka Nagatomo, et al.
Anticancer Research|June 20, 2013
Possible therapeutic targets among the molecules involved in the Warburg effect in tumor cellsSung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
International Journal of Hematology|July 17, 2016
Role of Geminin in cell fate determination of hematopoietic stem cells (HSCs)Shin'ichiro Yasunaga, Yoshinori Ohno, Naoto Shirasu, et al.
Stem Cell Research|July 9, 2018
Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A geneYasuyoshi Tanaka, Norimichi Higurashi, Naoto Shirasu, et al.
Anticancer Research|May 30, 2012
Biological response modifiers used in cancer biotherapyMasahide Kuroki, Shingo Miyamoto, Takashi Morisaki, et al.
Pageof 3